Evidence map›Paper›PMID 41993977›Full record

ArticleFrontiers in endocrinology2026

Differentiating obesity with and without prediabetes through skin findings: results from PREVIEW sub-study.

Razvigor Darlenski, Vesselina Mihaylova, Karen Manuelyan, Denitza Zheleva, Georgi Bogdanov, Ivan Bogdanov, Todor Kundurzhiev, Pavlina Gateva, Mikael Fogelholm, Anne Raben and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Razvigor DarlenskiDepartment of Dermatology and Venereology, Acibadem Cityclinic Tokuda Hospital, Sofia, Bulgaria.
Vesselina MihaylovaDepartment of Pharmacology and Toxicology, Medical Faculty, Medical University, Sofia, Bulgaria.
Karen ManuelyanDepartment of Dermatology and Venereology, Trakia University, Stara Zagora, Bulgaria.
Denitza ZhelevaDepartment of Dermatology and Venereology, Acibadem Cityclinic Tokuda Hospital, Sofia, Bulgaria.
Georgi BogdanovDepartment of Pharmacology and Toxicology, Medical Faculty, Medical University, Sofia, Bulgaria.
Ivan BogdanovDepartment of Dermatology and Venereology, Acibadem Cityclinic Tokuda Hospital, Sofia, Bulgaria.
Todor KundurzhievFaculty of Public Health, Medical University, Sofia, Bulgaria.
Pavlina GatevaDepartment of Pharmacology and Toxicology, Medical Faculty, Medical University, Sofia, Bulgaria.
Mikael FogelholmDepartment of Food and Environmental Sciences, University of Helsinki, Helsinki, Finland.
Anne RabenDepartment of Nutrition, Exercise and Sports, SCIENCE, University of Copenhagen, Copenhagen, Denmark.
Teodora Handjieva-DarlenskaDepartment of Pharmacology and Toxicology, Medical Faculty, Medical University, Sofia, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore whether specific cutaneous findings are associated with prediabetes among adults with overweight or obesity, and may assist in clinical risk stratification. Materials and methods: This single-center, cross-sectional analysis included 191 adults with overweight or obesity (BMI ≥25 kg/m²) recruited during screening visits of the Bulgarian PREVIEW cohort; 151 participants had prediabetes, and 40 did not. A trained dermatologist performed a standardized skin examination. Xerosis, pruritus, and yellowish skin tone were assessed using 10-point visual scales. The prevalence of dermatological conditions was compared between groups, and exploratory binary logistic regression was used to examine associations with prediabetes. Results: Horseshoe-like plantar hyperkeratosis (HSLPH) was more frequent in participants with prediabetes than in those without (25.2% vs. 10.0%, p = 0.039). The presence of HSLPH was associated with higher odds of prediabetes (odds ratio 3.03, 95% confidence interval 1.01-9.06). HSLPH showed high specificity (90%) but low sensitivity (25%). The prevalence of other common skin conditions, including skin tags, onychomycosis, signs of chronic venous insufficiency, seborrheic dermatitis, and tinea pedis, did not differ between groups. Skin tag counts were not associated with body weight or BMI. No significant differences were observed in xerosis, pruritus, or yellowish skin tone scores. Conclusion: In adults with overweight or obesity, HSLPH was the only cutaneous finding associated with prediabetes and behaved as a specific but insensitive clinical sign. Its presence may serve as a visible clinical red flag prompting metabolic evaluation, whereas its absence does not exclude dysglycemia. Other common obesity-related skin findings were not discriminatory for prediabetes in this cohort.

Indexed as

ObesityPrediabetic StateSkinSkin DiseasesAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedOverweightPrevalencediabetesinsulin resistanceoverweightplantar hyperkeratosisskin tag

Identifiers

PMID41993977
PMCPMC13079181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.